PTMN(PTMN)
PTMN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $66M | $64M |
| Low | $57M | $54M |
| High | $74M | $71M |
| EBITDA Avg | $41M | $40M |
| Low | $35M | $34M |
| High | $46M | $44M |
| EBIT Avg | $30M | $28M |
| Low | $25M | $24M |
| High | $33M | $32M |
| Net Income Avg | $22M | $18M |
| Low | $21M | $15M |
| High | $23M | $21M |
| EPS Avg | $1.99 | $1.66 |
| Low | $1.89 | $1.35 |
| High | $2.10 | $1.91 |
| Analysts (Rev / EPS) | 3 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $17M | $17M | $16M | $16M | $16M | $16M |
| Low | $17M | $17M | $16M | $16M | $16M | $16M |
| High | $17M | $17M | $16M | $16M | $16M | $16M |
| EBITDA Avg | $10M | $10M | $10M | $10M | $10M | $10M |
| Low | $10M | $10M | $10M | $10M | $10M | $10M |
| High | $10M | $10M | $10M | $10M | $10M | $10M |
| EBIT Avg | $7M | $7M | $7M | $7M | $7M | $7M |
| Low | $7M | $7M | $7M | $7M | $7M | $7M |
| High | $7M | $7M | $7M | $7M | $7M | $7M |
| Net Income Avg | $6M | $6M | $5M | $5M | $5M | $5M |
| Low | $6M | $6M | $5M | $5M | $5M | $5M |
| High | $6M | $6M | $5M | $5M | $5M | $5M |
| EPS Avg | $0.50 | $0.50 | $0.42 | $0.42 | $0.41 | $0.41 |
| Low | $0.50 | $0.50 | $0.42 | $0.42 | $0.41 | $0.41 |
| High | $0.50 | $0.50 | $0.42 | $0.42 | $0.41 | $0.41 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |